Jazz Pharmaceuticals
JAZZ
#1410
Rank
โ‚น1.369 T
Marketcap
โ‚น21,338
Share price
-2.62%
Change (1 day)
36.95%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2026 (TTM): โ‚น313.08

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น336.39. In 2025 the company made an earnings per share (EPS) of -โ‚น536.56 a decrease over its 2024 EPS that were of โ‚น844.22.

EPS history for Jazz Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น313.08-158.35%
2025-โ‚น536.56-163.56%
2024โ‚น844.2239.08%
2023โ‚น606.99-285.03%
2022-โ‚น328.05-34.2%
2021-โ‚น498.56-224.83%
2020โ‚น399.41-53.25%
2019โ‚น854.4223.59%
2018โ‚น691.32-8.24%
2017โ‚น753.4123.74%
2016โ‚น608.8422.12%
2015โ‚น498.56478.49%
2014โ‚น86.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น486.52 44.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
โ‚น768.23 128.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-โ‚น99.16-129.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
โ‚น41.70-87.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel